Social Media Ideas for Astragin

Latest updates for Astragin

Fresh curated links around AstraGin are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

bioengineer.org /1 week ago

Astragalus-Derived Zinc Oxide Nanoparticles Target Xanthine Oxidase and LasR

A plant native to Türkiye has been recruited to build a new kind of multifunctional nanomaterial: zinc oxide particles wrapped in the chemistry of Astragalus tokatensis. In a study...

Read source

blog.priceplow.com /1 month ago

Senactiv's Rg1 Boosts Muscle Mitochondria by 173% in Postmenopausal Women: New 2026 Study

Most of Senactiv's research story has been performed on young, trained men in their twenties. Cycling tests, squat sessions, and muscle biopsies from twenty-somethings pushing them...

Read source

blog.priceplow.com /1 month ago

VasoDrive-APÂ®: The Original Peptide Pre-Workout Pump Ingredient

Most stimulant-free pump ingredients work through a single pathway: nitric oxide production. Citrulline, arginine, and nitrates all lean on it. VasoDrive-APÂ® doesn't. It's a pepti...

Read source

prunderground.com /1 month ago

Asian‑Led NutriWorks® Elevates Holistic Health Power of Passion Fruit Seed Extract in Newly-Debuting RejuvenAge NMN 1800...

With global lifespans continuing to increase, consumers are overwhelmingly seeking products that not only improve their health, but return strength, youth, and vitality. Working to...

Read source

scmp.com /1 week ago

China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial

Chinese biopharmaceutical firm Akeso announced on Wednesday that its immunotherapy drug had outperformed AstraZeneca’s Imfinzi in a head-to-head phase-three trial for biliary tract...

Read source

biopharmadive.com /3 weeks ago

AstraZeneca scores in lung cancer; Sandoz inks a China deal

A combination of AstraZeneca’s Tagrisso and Hutchmed’s Orpathys extended survival for some lung cancer patients. Elsewhere, MapLight floated the idea of partnering on its autism dr...

Read source

fiercebiotech.com /1 week ago

ESC26: AstraZeneca's heart failure drug shows promise in ph. 2 trial

AstraZeneca’s oral relaxin agonist delivered encouraging phase 2b results in chronic heart failure, improving measures of cardiac function across two patient groups.

Read source

medcitynews.com /1 month ago

AstraZeneca Turns to China for Molecule That Might Top New Merck COPD Drug

AstraZeneca is getting rights to a Sino Biopharmaceutical drug that offers a dual mechanism to treat chronic obstructive pulmonary disease, or COPD. It’s the same approach as an FD...

Read source

blog.priceplow.com /4 weeks ago

Unmatched Supps Longevity Greens+: Kris Gethin's All-In-One Greens, Reds, and Probiotic Formula

Unmatched Supps has spent the last several releases blurring the line between performance and longevity, and its newest launch also brings that mentality to the daily greens catego...

Read source

genengnews.com /1 month ago

AstraZeneca Licenses Global Rights to Dizal Lung Cancer Drug for Up-to-$1.5B

Dizal has been pursuing approvals from the FDA and China’s Center for Drug Evaluation (CDE) for a new indication for Zegfrovy, as a first-line treatment for NSCLC with exon 20 inse...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.